Table 1.
Baseline characteristics of 41 patients with Mycobacterium avium complex lung disease who were treated with a moxifloxacin-containing antibiotic regimen
| Patient characteristica | Valuesb |
|---|---|
| Age, yr | 65 (56–71) |
| Male | 28 (68) |
| Body mass index, kg/m2 | 19.5 (18.2–21.2) |
| Current or ex-smoker | 19 (46) |
| History of previous tuberculosis | 29 (71) |
| Pulmonary function test | |
| FEV1 | 84% (65–94%) |
| FVC | 75% (63–90%) |
| FEV1/FVC | 80% (69–89%) |
| Etiologic organism | |
| Mycobacterium avium | 15 (37) |
| Mycobacterium intracellulare | 26 (63) |
| Positive sputum AFB smearc | 29 (71) |
| No. of involved lobes | 4 (3–4) |
| Type of disease | |
| Fibrocavitary form | 19 (46) |
| Nodular bronchiectatic form | 20 (49) |
| Unclassifiable form | 2 (5) |
a
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; AFB, acid-fast bacillus.
b
Data represent number (percent) or median (interquartile [IQR] range) except where otherwise indicated.
c
Data represent patient status at the time of start of moxifloxacin treatment.